Enspryng

Made by

• Chugai (Roche)

Active Ingredient

Satralizumab (genetical recombination)

Prospectus

Approval date

2020/6/29

Treats

• Neuromyelitis optica, Devic disease

Dosages

• ENSPRYNG Syringes for Subcutaneous Injection - 1532660円／筒